Cargando…
608. Evaluation of Safety of High-Dose Beta-Lactam Antibiotics in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study
BACKGROUND: Beta-lactam toxicity is often underestimated in clinical practice given the insidious onset and complex clinical picture of patients. Renally impaired patients are at increased risk of toxicity due to drug accumulation, which may increase their morbidity and mortality. This study’s objec...
Autores principales: | Varona, Jerald, FakhriRavari, Alireza, Hassan, Abbas, Trieu, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751554/ http://dx.doi.org/10.1093/ofid/ofac492.660 |
Ejemplares similares
-
Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
por: FakhriRavari, Alireza, et al.
Publicado: (2022) -
Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection
por: FakhriRavari, Alireza, et al.
Publicado: (2016) -
Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
por: FakhriRavari, Alireza, et al.
Publicado: (2021) -
Beta-lactam antibiotic test doses in the emergency department
por: Maguire, Michelle, et al.
Publicado: (2020) -
Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance
por: Band, Victor I., et al.
Publicado: (2021)